RB1 and osteosarcoma: Mutations in p53 and/or Rb genes, as well as other components involved in their pathways, have been identified in human osteogenic sarcoma patients, and mouse models for studying the cell of origin for osteogenic sarcoma have been developed via conditional mesenchymal/osteogenic lineage-restricted knockout of p53 and/or Rb genes (5–9).